Zhi Yang

4.5k citations
113 papers · 3.0k indexed · h-index 30
Topics
CAR-T cell therapy research (13 papers)Cancer Cells and Metastasis (11 papers)MicroRNA in disease regulation (8 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Zhi Yang

103 papers receiving 3.0k citations

Peers

Zhi Yang
Comparison fields: 5 of 123
  • Molecular Biology 1.6k
  • Cancer Research 891
  • Oncology 832
  • Pulmonary and Respiratory Medicine 330
  • Surgery 310
Replace Liming Wang with:
Liming Wang China
Jingjing Yang China
Zhipeng Han China
Azeddine Atfi France
Mamoru Uemura Japan
Koichi Kawamoto Japan
Ying Chang China
Xinxiang Li China
Min Tao China
Zhi Yang relative to Liming Wang China Liming Wang's profile →
Citations per field
00.5×1.5×
Liming Wang · 1×
Citations per year

Countries citing papers authored by Zhi Yang

Since Specialization
Citations

This map shows the geographic impact of Zhi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Yang more than expected).

Fields of papers citing papers by Zhi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Yang. The network helps show where Zhi Yang may publish in the future.

Co-authorship network of co-authors of Zhi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Yang. A scholar is included among the top collaborators of Zhi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Yang. Zhi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 1
4 0
5 1
6 1
7 5
8 1
9 8
10 0
11 5
12 31
13 11
14 6
15 9
16 57
17 74
18
The effect of BDNF on maturation in-vitro and developmental competence of murine immature oocytes
1
19 44
20
The Antitumor and Improving Immunological Functions Effect of Moxibustion
1

About Zhi Yang

Zhi Yang is a scholar working on Oncology, Cancer Research and Hepatology, having authored 113 papers that have together received 3.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Cancer Cells and Metastasis (11 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (891 citations), Oncology (832 citations) and Hepatology (209 citations). Zhi Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Cheng Qian, Juanjuan Shan, Yanmin Xu, Limei Liu, Junjie Shen, Xiu‐Wu Bian, You‐Hong Cui, Leina Ma, Chungang Liu and X Y Feng. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026